Search Clinical Trials
598,193 trials
ID
Status
Phase
Title
Sponsor
NCT07763951
Clinical Study to Determine Bioequivalence Between Two Oral Medications of Sitagliptin/Metformin in Prolonged-release Tablets With 100 mg/1000 mg in Healthy Subjects, Fast Study.ADIUMCompletedNot Applicable
NCT07763951Completed
Not Applicable
Clinical Study to Determine Bioequivalence Between Two Oral Medications of Sitag...ADIUM
NCT07764211
Multimodal Cohort Study of Generalized Anxiety DisorderShanghai Mental Health CenterNot Yet Recruiting
NCT07764211Not Yet Recruiting
—
Multimodal Cohort Study of Generalized Anxiety DisorderShanghai Mental Health Ce...
NCT07763171
Paclitaxel, Ramucirumab and Tislelizumab Switch Maintenance in Advanced HER2-negative and PD-L1 TAP Score of 5 or More Advanced Gastroesophageal AdenocarcinomaGruppo Oncologico del Nord-OvestNot Yet RecruitingPhase 3
NCT07763171Not Yet Recruiting
Phase 3
Paclitaxel, Ramucirumab and Tislelizumab Switch Maintenance in Advanced HER2-neg...Gruppo Oncologico del Nor...
NCT07762807
Colchicine And Dialysis Patients; a Feasibility StudyGuy's and St Thomas' NHS Foundation TrustRecruitingNot Applicable
NCT07762807Recruiting
Not Applicable
Colchicine And Dialysis Patients; a Feasibility StudyGuy's and St Thomas' NHS...
NCT07762183
Dependence, Frailty, and Kinesiophobia on Early Postoperative Mobilization and Self-Care Ability in Patients Undergoing Lumbar Disc Herniation SurgeryAydin Adnan Menderes UniversityCompleted
NCT07762183Completed
—
Dependence, Frailty, and Kinesiophobia on Early Postoperative Mobilization and S...Aydin Adnan Menderes Univ...
NCT07762872
A Multicenter Prospective Real-World Effectiveness and Safety of Satralizumab in the Early Treatment of Attacks in NMOSDChifeng Municipal HospitalRecruiting
NCT07762872Recruiting
—
A Multicenter Prospective Real-World Effectiveness and Safety of Satralizumab in...Chifeng Municipal Hospita...
NCT07763912
Clinical Study to Determine Bioequivalence Between Two Oral Medications of Sitagliptin/Metformin in Prolonged-release Tablets With 50 mg/1000 mg in Healthy Subjects, Fed Study.ADIUMCompletedNot Applicable
NCT07763912Completed
Not Applicable
Clinical Study to Determine Bioequivalence Between Two Oral Medications of Sitag...ADIUM
NCT07762105
Study of Atorvastatin and Its Effects in Clinical and Radiological Aspects in Patients With Moderate-to-Severe Thyroid Eye DiseaseBanu Aji DibyasaktiNot Yet RecruitingPhase 1
NCT07762105Not Yet Recruiting
Phase 1
Study of Atorvastatin and Its Effects in Clinical and Radiological Aspects in Pa...Banu Aji Dibyasakti
NCT07762170
Success Rates and Safety of Steroid Injections in Managing Spinal and Sacro-Iliac Pain (CORTisone Injection Spine Study)Igor Wilderman. MDRecruitingPhase 4
NCT07762170Recruiting
Phase 4
Success Rates and Safety of Steroid Injections in Managing Spinal and Sacro-Ilia...Igor Wilderman. MD
NCT07763873
A Study Examining Acceptability of Auditory Implant Fitting Software TechnologiesCochlearNot Yet RecruitingNot Applicable
NCT07763873Not Yet Recruiting
Not Applicable
A Study Examining Acceptability of Auditory Implant Fitting Software Technologie...Cochlear
NCT07762898
Sedentary Behavior Intervention for Older Adults With Coronary Heart Disease and FrailtyGansu University of Chinese MedicineNot Yet RecruitingNot Applicable
NCT07762898Not Yet Recruiting
Not Applicable
Sedentary Behavior Intervention for Older Adults With Coronary Heart Disease and...Gansu University of Chine...
NCT07764094
Impact of Procedural Factors on Drug-Coated Balloon Outcomes in Coronary Artery DiseaseNanjing First Hospital, Nanjing Medical UniversityRecruiting
NCT07764094Recruiting
—
Impact of Procedural Factors on Drug-Coated Balloon Outcomes in Coronary Artery...Nanjing First Hospital, N...
NCT07762404
Reconstruction of First Web Space After Trauma and BurnSohag UniversityNot Yet RecruitingNot Applicable
NCT07762404Not Yet Recruiting
Not Applicable
Reconstruction of First Web Space After Trauma and BurnSohag University
NCT07762261
Impact of Generative AI on University Students' Learning Processes and Critical ThinkingAtaturk UniversityNot Yet RecruitingNot Applicable
NCT07762261Not Yet Recruiting
Not Applicable
Impact of Generative AI on University Students' Learning Processes and Critical...Ataturk University
NCT07762508
A Prospective Single-Arm Study of VABu Conditioning Regimen in Allo-HSCT for Low-Performance or High-Comorbidity AML Patients in CR1The First Affiliated Hospital of Soochow UniversityNot Yet RecruitingNot Applicable
NCT07762508Not Yet Recruiting
Not Applicable
A Prospective Single-Arm Study of VABu Conditioning Regimen in Allo-HSCT for Low...The First Affiliated Hosp...
NCT07764276
Enhanced Recovery After Surgery (ERAS) in Patients Undergoing Gynecologic SurgeryNational Taiwan University HospitalRecruitingNot Applicable
NCT07764276Recruiting
Not Applicable
Enhanced Recovery After Surgery (ERAS) in Patients Undergoing Gynecologic Surger...National Taiwan Universit...
NCT07764107
Photobiomodulation for Reducing Sedative-Hypnotic Use:Clinical Trial of a Light-Therapy DeviceNational Health Research Institutes, TaiwanNot Yet RecruitingNot Applicable
NCT07764107Not Yet Recruiting
Not Applicable
Photobiomodulation for Reducing Sedative-Hypnotic Use:Clinical Trial of a Light-...National Health Research...
NCT07762703
Combination Immunotherapy Treatment for Locally Advanced Unresectable or Metastatic, PD-L1 Negative (CPS<10), gBRCA Negative, Triple Negative Breast Cancer Including BreakVax ImmunoTreatment (Designed and Manufactured Per Patient), Chemotherapy and Anti PD-1 TherapyBreakBio CorpNot Yet RecruitingPhase 1
NCT07762703Not Yet Recruiting
Phase 1
Combination Immunotherapy Treatment for Locally Advanced Unresectable or Metasta...BreakBio Corp
NCT07762976
Dynamic Risk-adapted EBV-DNA and MRI-guided De-concurrent Chemotherapy in Nasopharyngeal CarcinomaFudan UniversityRecruitingPhase 2
NCT07762976Recruiting
Phase 2
Dynamic Risk-adapted EBV-DNA and MRI-guided De-concurrent Chemotherapy in Nasoph...Fudan University
Result Breakdown
Not yet recruiting11 (55%)
Recruiting6 (30%)
Completed3 (15%)
not_applicable10 (50%)
Not Specified4 (20%)
Phase 12 (10%)
Phase 22 (10%)
Phase 31 (5%)
Phase 41 (5%)